For decades, we have been predicting, preventing, and controlling infectious disease outbreaks around the world.
In partnership with government and commercial clients, our important breakthroughs in diagnostics and medical countermeasures are used to understand and mitigate the impacts of zoonotic diseases and biological agent threats. For diseases like Ebola, SARS, MERS, and SARS-CoV-2, the diagnostic assays we develop and deploy save lives.
About Vaccines & therapeutics
Infectious diseases have been a threat to humans throughout recorded history.
From our work in the laboratory testing new diagnostic devices or deployments in field-forward settings to support the localized response to a disease outbreak, our research scientists understand these threats and how to combat them. We also know that due to climate change and other factors, it is only a matter of time until a new disease emerges to threaten human health.
What We Do
Research & Development
Why MRIGlobal?
Our experience and laboratories are unmatched, providing the expertise our customers have relied on for decades.
Featured News
Five Diseases Tied to Climate Change
Global Health Surveillance Human Health
Weather Extremes Drive Increased Incidence of Infectious Diseases With recent changes in weather toward warm… Read More
Work With Us
Your challenges inspire our scientists.
We work with government agencies, academic institutions, and commercial businesses every year to help further unbiased research and innovative development.